Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00356317 · ClinicalTrials.gov registry record · Phase 2
Culturally Based Family Therapy for Improving Treatment Outcome for People With Schizophrenia
A Phase 2 study of Schizophrenia, sponsored by University of Miami.
- Completed
- Registry status
- Phase 2
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT00356317 is a Phase 2 study of Schizophrenia that has completed, run by University of Miami. The registered enrollment target is 400 participants, above the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (83% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00356317, a Phase 2 study of Schizophrenia, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effectiveness of a culturally based family therapy intervention in improving treatment outcome in people with schizophrenia.
Conditions Studied
Interventions
- BEHAVIORAL Culturally informed therapy for schizophrenia (CIT-S)
- BEHAVIORAL Psychoeducation treatment as usual
Study Locations (1)
Florida
- University of Miami - Coral Gables
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2015-03 |
| Est. Completion | 2015-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00356317
The ClinicalTrials.gov registry entry for NCT00356317 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (83% higher). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Culturally informed therapy for schizophrenia (CIT-S) is the first listed.
NCT00356317 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT00356317 about?
NCT00356317 is a clinical study titled "Culturally Based Family Therapy for Improving Treatment Outcome for People With Schizophrenia". This study will evaluate the effectiveness of a culturally based family therapy intervention in improving treatment outcome in people with schizophrenia.
What is the current status of trial NCT00356317?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 400 participants. The study started on 2015-03. Estimated completion is 2015-03.
What conditions does trial NCT00356317 study?
This clinical trial studies the following conditions: Schizophrenia.
What interventions are being tested in trial NCT00356317?
The interventions under investigation include: Culturally informed therapy for schizophrenia (CIT-S) (BEHAVIORAL), Psychoeducation treatment as usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT00356317?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00356317 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
RECRUITING · Phase 2
-
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia
RECRUITING · Phase 2
-
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
RECRUITING · Phase 2
-
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
RECRUITING · Phase 2
-
Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia
RECRUITING · Phase 2
-
Study of ALTO-101 in Patients With Schizophrenia
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.